Nalaganje...
Maintenance Rituximab or Observation after Frontline Treatment with Bendamustine-Rituximab for Follicular Lymphoma
Bendamustine (B) with rituximab (R) is a standard frontline treatment for medically fit follicular lymphoma (FL) patients. The safety and efficacy of maintenance rituximab (MR) after BR induction has not been formally compared to observation for FL, resulting in disparate practice patterns. Prospect...
Shranjeno v:
| izdano v: | Br J Haematol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6486816/ https://ncbi.nlm.nih.gov/pubmed/30575016 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.15720 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|